Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
187,380,108
-
Share change
-
+1,074,174
-
Total reported value
-
$50,837,222,531
-
Put/Call ratio
-
114%
-
Price per share
-
$271.36
-
Number of holders
-
991
-
Value change
-
+$288,984,209
-
Number of buys
-
413
-
Number of sells
-
483
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q2 2017
As of 30 Jun 2017,
BIOGEN INC. - COM (BIIB) was held by
991 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
187,380,108 shares.
The largest 10 holders included
BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, STATE STREET CORP, Clearbridge Investments, LLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Invesco Ltd., and NORTHERN TRUST CORP.
This page lists
992
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.